<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Garcia-Marquez MA</submitter><funding>Deutsche Forschungsgemeinschaft</funding><pagination>e007268</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11029431</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The individual HLA-I genotype is associated with cancer, autoimmune diseases and infections. This study elucidates the role of germline homozygosity or allelic imbalance of HLA-I loci in esophago-gastric adenocarcinoma (EGA) and determines the resulting repertoires of potentially immunogenic peptides.&lt;h4>Methods&lt;/h4>HLA genotypes and sequences of either (1) 10 relevant tumor-associated antigens (TAAs) or (2) patient-specific mutation-associated neoantigens (MANAs) were used to predict good-affinity binders using an in silico approach for MHC-binding (www.iedb.org). Imbalanced or lost expression of HLA-I-A/B/C alleles was analyzed by transcriptome sequencing. FluoroSpot assays and TCR sequencing were used to determine peptide-specific T-cell responses.&lt;h4>Results&lt;/h4>We s</pubmed_abstract><journal>Journal for immunotherapy of cancer</journal><pubmed_title>Germline homozygosity and allelic imbalance of HLA-I are common in esophagogastric adenocarcinoma and impair the repertoire of immunogenic peptides.</pubmed_title><pmcid>PMC11029431</pmcid><funding_grant_id>No. 325827080 and No. 418074181</funding_grant_id><pubmed_authors>George J</pubmed_authors><pubmed_authors>Peifer M</pubmed_authors><pubmed_authors>Muller P</pubmed_authors><pubmed_authors>Bruns C</pubmed_authors><pubmed_authors>Gathof B</pubmed_authors><pubmed_authors>Bauer E</pubmed_authors><pubmed_authors>Nikolic M</pubmed_authors><pubmed_authors>Yazbeck AM</pubmed_authors><pubmed_authors>Hillmer AM</pubmed_authors><pubmed_authors>von Bergwelt-Baildon M</pubmed_authors><pubmed_authors>Schloßer HA</pubmed_authors><pubmed_authors>Garcia-Marquez MA</pubmed_authors><pubmed_authors>Keller D</pubmed_authors><pubmed_authors>Wennhold K</pubmed_authors><pubmed_authors>Zander T</pubmed_authors><pubmed_authors>Schroder W</pubmed_authors><pubmed_authors>Thelen M</pubmed_authors><pubmed_authors>Thomas R</pubmed_authors><pubmed_authors>Quaas A</pubmed_authors><pubmed_authors>Lehmann J</pubmed_authors><pubmed_authors>Maas L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Germline homozygosity and allelic imbalance of HLA-I are common in esophagogastric adenocarcinoma and impair the repertoire of immunogenic peptides.</name><description>&lt;h4>Background&lt;/h4>The individual HLA-I genotype is associated with cancer, autoimmune diseases and infections. This study elucidates the role of germline homozygosity or allelic imbalance of HLA-I loci in esophago-gastric adenocarcinoma (EGA) and determines the resulting repertoires of potentially immunogenic peptides.&lt;h4>Methods&lt;/h4>HLA genotypes and sequences of either (1) 10 relevant tumor-associated antigens (TAAs) or (2) patient-specific mutation-associated neoantigens (MANAs) were used to predict good-affinity binders using an in silico approach for MHC-binding (www.iedb.org). Imbalanced or lost expression of HLA-I-A/B/C alleles was analyzed by transcriptome sequencing. FluoroSpot assays and TCR sequencing were used to determine peptide-specific T-cell responses.&lt;h4>Results&lt;/h4>We s</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-06-15T06:15:49.253Z</modification><creation>2026-06-15T03:08:39.132Z</creation></dates><accession>S-EPMC11029431</accession><cross_references><pubmed>38631707</pubmed><doi>10.1136/jitc-2023-007268</doi></cross_references></HashMap>